Exhibit 99.1

                 Possis Medical, Inc., to Present at
               the UBS Global Life Sciences Conference

    MINNEAPOLIS--(BUSINESS WIRE)--Sept. 17, 2007--Possis Medical, Inc.
(NASDAQ:POSS), today announced that it is participating in the UBS
Global Life Sciences Conference at The Grand Hyatt Hotel in New York
on Thursday, September 27, 2007. Jules Fisher, vice president of
finance and CFO, is scheduled to present a company overview and
discuss Possis' pioneering medical technologies to conference
attendees at 8:00 a.m. ET.

    A live webcast of the presentation will be available at 8:00 a.m.
ET on Thursday, September 27, at www.ibb.ubs.com. A replay will be
available beginning approximately three hours after the live
presentation at the same address until October 27, 2007. Access to
this site is public. A copy of the presentation materials will be
available at www.possis.com.

    Possis Medical, Inc., develops, manufactures and markets
pioneering medical devices for the large and growing cardiovascular
and vascular treatment markets. The company's AngioJet System is the
world's leading mechanical thrombectomy system with FDA approval to
remove large and small thrombus from coronary arteries, coronary
bypass grafts, peripheral arteries and veins, A-V grafts and native
fistulas.

    CONTACT: Possis Medical, Inc.
             Jules L. Fisher, 763-450-8011
             Vice President, Finance and
             Chief Financial Officer
             Jules.Fisher@possis.com